
HSCT Group - National Cancer Institute - Fellows @ChelisBR @FerGvhd1221
Mexico, MD
Joined March 2025
- Tweets440
- Following298
- Followers117
- Likes436
Your research could help shape the future of transplantation and cellular therapy. Submit an abstract to Tandem Meetings 2027 to gain visibility, receive valuable feedback from peers, and share your findings with an international audience of clinicians, investigators, and healthcare professionals.
🔗 Start your submission today: ow.ly/RRJJ50ZSj8r
🗣️ Present your work at one of the most influential global congresses in HCT, cellular therapy and gene therapy in Rotterdam. #EBMT27
Give your research the chance to gain global recognition and explore available awards, grants, abstract topics, and more ➡️ ebmt.org/annual-meeting/abst…
#HCT #CellTherapy #hematology #Research #Abstracts
Cofepris autoriza el primer ensayo clínico en México con células CAR-T de manufactura nacional, desarrollado por la Universidad Autónoma de Nuevo León (UANL). 🔬🇲🇽
Tras una rigurosa evaluación científica, técnica y ética, autorizamos el protocolo que se llevará a cabo de manera integral en el Hospital Universitario “Dr. José Eleuterio González”: obtención, modificación genética y administración celular en personas adultas con leucemia linfoblástica aguda recidivante o refractaria.
Con esta acción, también se sientan nuevas bases normativas para el desarrollo seguro de terapias avanzadas y consolida la capacidad de investigación científica nacional. ⚖️📋
Ver detalles: gob.mx/cofepris/articulos/co…
#Cofepris #UANL #EnsayosClínicos #TerapiasAvanzadas #SaludPública #RegulaciónSanitaria #CélulasCART
📣𝘏𝘢𝘱𝘱𝘦𝘯𝘪𝘯𝘨 𝘰𝘯 𝘞𝘌𝘋𝘕𝘌𝘚𝘋𝘈𝘠:
𝗜𝗔𝗖𝗛 𝗣𝗼𝘀𝘁 𝗜𝗠𝗦 𝟮𝟬𝟮𝟲 𝗿𝗼𝘂𝗻𝗱𝘁𝗮𝗯𝗹𝗲
𝘈 𝘳𝘰𝘶𝘯𝘥𝘵𝘢𝘣𝘭𝘦 𝘥𝘪𝘴𝘤𝘶𝘴𝘴𝘪𝘰𝘯 𝘥𝘦𝘥𝘪𝘤𝘢𝘵𝘦𝘥 𝘵𝘰 𝘵𝘩𝘦 𝘭𝘢𝘵𝘦𝘴𝘵 𝘢𝘥𝘷𝘢𝘯𝘤𝘦𝘴 𝘪𝘯 𝘮𝘶𝘭𝘵𝘪𝘱𝘭𝘦 𝘮𝘺𝘦𝘭𝘰𝘮𝘢 𝘢𝘯𝘥 𝘵𝘩𝘦 𝘬𝘦𝘺 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵𝘴 𝘦𝘮𝘦𝘳𝘨𝘪𝘯𝘨 𝘧𝘳𝘰𝘮 𝘳𝘦𝘤𝘦𝘯𝘵 𝘴𝘤𝘪𝘦𝘯𝘵𝘪𝘧𝘪𝘤 𝘮𝘦𝘦𝘵𝘪𝘯𝘨𝘴
𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗙𝗥𝗘𝗘 →
us06web.zoom.us/webinar/regi…
𝘸𝘪𝘵𝘩 𝘕𝘪𝘻𝘢𝘳 𝘑. 𝘉𝘢𝘩𝘭𝘪𝘴, 𝘊𝘦𝘳𝘪 𝘉𝘺𝘨𝘳𝘢𝘷𝘦, 𝘔𝘦𝘭𝘦𝘵𝘪𝘰𝘴-𝘈𝘵𝘩𝘢𝘯𝘢𝘴𝘪𝘰𝘴 𝘋𝘪𝘮𝘰𝘱𝘰𝘶𝘭𝘰𝘴, 𝘏𝘦𝘳𝘮𝘢𝘯𝘯 𝘌𝘪𝘯𝘴𝘦𝘭𝘦, 𝘔𝘢𝘳𝘪́𝘢 𝘝𝘪𝘤𝘵𝘰𝘳𝘪𝘢 𝘔𝘢𝘵𝘦𝘰𝘴, 𝘏𝘪𝘳𝘢 𝘔𝘪𝘢𝘯 𝘢𝘯𝘥 𝘗𝘢𝘶𝘭𝘢 𝘙𝘰𝘥𝘳𝘪́𝘨𝘶𝘦𝘻 𝘖𝘵𝘦𝘳𝘰
@NBahlis @BygraveCeri @thanosdimop @H_Einsele
@mvmateos @HiraSMian @paurotero @Mohty_EBMT
@COMyCongress
Managing toxicities remains one of the most critical and rapidly evolving aspects of transplantation and cellular therapy. Join experts at the ASTCT Toxicities Conference for practical guidance, emerging research, and multidisciplinary discussions on recognizing, preventing, and managing treatment-related toxicities across a variety of cellular therapies.
🔗 Register today: ow.ly/hxRB50ZPMMv
Grupo Trasplante INC retweeted
👉👉👉Meet up of the #heme minds together @UTMDAnderson today ! @HindRafei @pbachi #leusm #bmtsm #MPNSM #BPDCN #ImmunoOnc | @Transplant_Doc 🙌 ||| #endcancer
Grupo Trasplante INC retweeted
🩸 ¡AÚN ESTÁS A TIEMPO!
🧑🏫 VI Jornadas Clínicas del Grupo Estudio Latinoamericano de Linfoproliferativos @Grupo_GELL
📆 25-26 septiembre 2026
📍 Panamá 🇵🇦
✍️ Inscríbete 👉 docs.google.com/forms/d/e/1F…
#Hematología #HematologíaEnEspañol #lymsm
What’s next for CAR T? At #CEC2026, @bmtdoc63 will explore CAR T beyond today’s approved applications—from emerging cellular therapy approaches to challenges in solid tumors and expanding patient access. Explore the full CEC program and register today: astct.org/Clinical-Education…
Grupo Trasplante INC retweeted
Read on updates to the 2012 ASBMT acute #GVHD guidelines, including consensus recommendations on acute GVHD staging and grading, the clinical role of biomarkers and risk-stratification tools and acute GVHD treatment. astctjournal.org/article/S26…
Felicitamos a la nueva mesa directiva de la SMTT por su nombramiento en su periodo 2026-2028, les auguramos éxito y un trabajo articulado en pro del crecimiento académico y asistencial del trasplante en toda la República Mexicana 🇲🇽🩸 – at Benito Juárez, Distrito Federal
Felicitamos al Dr. Luis Valero (@valerotmo) por su nombramiento como presidente 2026-2028 de la Sociedad Mexicana de Trasplante y Terapia Celular.
Grupo Trasplante INC retweeted
🧬 Flow Cytometry Demystified 🔬
🎥 Watch this video for a clear, practical approach to understanding how flow cytometry is used
🔗 Full video: youtu.be/cIS5W-ftVRY
#HematologyOncology #HemOnc #Immunophenotyping #MedEd @realbowtiedoc @HemOncFellows @IMG_Oncologists
Grupo Trasplante INC retweeted
This long-term follow-up study found that CD19 #CART therapy yielded sustained remissions in R/R B-NHL. High tumor Ki-67 was a poor prognostic factor and was associated with limited CAR-T cell expansion, especially CD8+ cells. Read: astctjournal.org/article/S26…
📣 Join the next Inborn Errors Working Party Live Forum Session on IEI 📣
🗓️ Tuesday 1 September
⏰ 16:00–17:00 CEST
This online meeting will feature challenging cases and expert-led discussion on HCT indication, timing, conditioning strategies, donor selection, and other procedural considerations.
➡️Register now: ebmt.webex.com/webappng/site…
#HCT #PatientCare #ClinicalCase #InbornErrors
Grupo Trasplante INC retweeted
This GATMO-TC experience found 3-year overall survival exceeded 85% after haploidentical HCT for severe aplastic anemia and exceeded 90% with upfront haplo-HCT. Graft failure occurred in 4.5% of patients. Read more: astctjournal.org/article/S26…
Could donor selection further reduce relapse risk in AML and MDS? New findings suggest permissive HLA-DPB1 mismatches combined with post-transplant cyclophosphamide may lower relapse without increasing GVHD or non-relapse mortality.
Read more: ow.ly/2Ay750ZA1ZV
Grupo Trasplante INC retweeted
Allogeneic Stem Cell Transplantation—A Salvage Option for High-Risk Chronic Lymphocytic Leukemia Patients: A 15-Year Single-Center Experience
onlinelibrary.wiley.com/doi/…
Grupo Trasplante INC retweeted
Happy to share our recent review on maintenance therapy post allo-BMT for myeloid malignancies 👇🏽
ovid.com/10.1097/MOH.0000000…
Nominations are now open for ASTCT’s Premier Awards, honoring individuals whose contributions have made a meaningful impact on the field through leadership, scientific achievement, clinical excellence, mentorship and service.
Recipients will be recognized at the 2027 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR®.
Submit a nomination: astct.org/Careers/Awards



























